Improving safety vs efficacy of duodenal jejunal bypass liner treatment for type 2 diabetes and obesity

Presented at EASD 61th Annual Meeting, Vienna, September 2025

R.E.J. Ryder¹, R. Drummond², B. McGowan³, S. Amiel⁴, R. Lopez-Gonzalez⁵, J. Pujol⁵, H. Frydenberg⁶, J. Stein⁷, T. Battelino⁸, S. Fishman⁹, C. de Jonge¹⁰, J. Greve¹¹, R. Cohen¹², M. Yadagiri¹, P. Sen Gupta³;

¹City Hospital, Birmingham, UK, ²Glasgow Royal Infirmary, Glasgow, UK, ³Guy's and St Thomas' NHS Foundation Trust, London, UK, ⁴Kings College Hospital NHS Foundation Trust, London, UK, ⁵Consorci Sanitari Integral, Barcelona, Spain, ⁶Epworth Centre for Bariatric Surgery, Richmond, Australia, ⁷Frankfurt-Sachsenhausen, Frankfurt, Germany, ⁸University Medical Center Ljubljana, Ljubljana, Slovenia, ⁹Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ¹⁰MaastrichtUniversity Medical Center, Maastricht, Netherlands, ¹¹MaastrichtUniversity Medical Center, Maastricht, UK, ¹²Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.